IVAX Financial Forecast

Abstract: A 6 page paper examining this pharmaceutical company's performance over the past years for the purpose of developing a pro forma statement for the next two years. The company is not yet ten years old but already has had to restructure. It appears to have solved its early problems and analysts now list it as a strong buy. Forecast growth for the next two years is 11 percent followed by 8 percent the following year (2002). Bibliography lists 3 sources.

Filename: KS-IVAXfinance.wps

Pages: 6

---

Catagory:

Subcatagory: Money & Banking / Corporate Finance

---